 | • レポートコード：MRC2-11QY09117 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は関節リウマチ治療薬のグローバル市場について調査・分析したレポートです。種類別（処方薬、市販薬）市場規模、用途別（病院、クリニック、老人ホーム、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別関節リウマチ治療薬の競争状況、市場シェア ・世界の関節リウマチ治療薬市場：種類別市場規模 2015年-2020年（処方薬、市販薬） ・世界の関節リウマチ治療薬市場：種類別市場規模予測 2021年-2026年（処方薬、市販薬） ・世界の関節リウマチ治療薬市場：用途別市場規模 2015年-2020年（病院、クリニック、老人ホーム、その他） ・世界の関節リウマチ治療薬市場：用途別市場規模予測 2021年-2026年（病院、クリニック、老人ホーム、その他） ・北米の関節リウマチ治療薬市場分析：米国、カナダ ・ヨーロッパの関節リウマチ治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの関節リウマチ治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の関節リウマチ治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの関節リウマチ治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AbbVie、Amgen、Bayer、Biogen、Boehringer Ingelheim、Bristol-Myers Squibb、F. Hoffmann-La Roche、Johnson and Johnson、Merck、Mitsubishi Tanabe Pharma、Novartis、Pfizer、UCB S.A ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Rheumatoid Arthritis Drugs include prescription and OTC.
The increasing prevalence of arthritis, the increasing acceptance of biopharmaceuticals, and the development of clear regulatory guidelines are major trends that are expected to trigger market growth.
Market Analysis and Insights: Global Rheumatoid Arthritis Drugs Market
The global Rheumatoid Arthritis Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Rheumatoid Arthritis Drugs Scope and Market Size
Rheumatoid Arthritis Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Rheumatoid Arthritis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Rheumatoid Arthritis Drugs market is segmented into
Prescription Drugs
Over-the-counter Drugs
Segment by Application, the Rheumatoid Arthritis Drugs market is segmented into
Hospital
Clinic
Nursing home
Other
Regional and Country-level Analysis
The Rheumatoid Arthritis Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Rheumatoid Arthritis Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Rheumatoid Arthritis Drugs Market Share Analysis
Rheumatoid Arthritis Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Rheumatoid Arthritis Drugs business, the date to enter into the Rheumatoid Arthritis Drugs market, Rheumatoid Arthritis Drugs product introduction, recent developments, etc.
The major vendors covered:
AbbVie
Amgen
Bayer
Biogen
Boehringer Ingelheim
Bristol-Myers Squibb
F. Hoffmann-La Roche
Johnson and Johnson
Merck
Mitsubishi Tanabe Pharma
Novartis
Pfizer
UCB S.A
1 Study Coverage
1.1 Rheumatoid Arthritis Drugs Product Introduction
1.2 Market Segments
1.3 Key Rheumatoid Arthritis Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Rheumatoid Arthritis Drugs Market Size Growth Rate by Type
1.4.2 Prescription Drugs
1.4.3 Over-the-counter Drugs
1.5 Market by Application
1.5.1 Global Rheumatoid Arthritis Drugs Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Nursing home
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Rheumatoid Arthritis Drugs Market Size, Estimates and Forecasts
2.1.1 Global Rheumatoid Arthritis Drugs Revenue 2015-2026
2.1.2 Global Rheumatoid Arthritis Drugs Sales 2015-2026
2.2 Global Rheumatoid Arthritis Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Rheumatoid Arthritis Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Rheumatoid Arthritis Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Rheumatoid Arthritis Drugs Competitor Landscape by Players
3.1 Rheumatoid Arthritis Drugs Sales by Manufacturers
3.1.1 Rheumatoid Arthritis Drugs Sales by Manufacturers (2015-2020)
3.1.2 Rheumatoid Arthritis Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Rheumatoid Arthritis Drugs Revenue by Manufacturers
3.2.1 Rheumatoid Arthritis Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Rheumatoid Arthritis Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Rheumatoid Arthritis Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Rheumatoid Arthritis Drugs Revenue in 2019
3.2.5 Global Rheumatoid Arthritis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Rheumatoid Arthritis Drugs Price by Manufacturers
3.4 Rheumatoid Arthritis Drugs Manufacturing Base Distribution, Product Types
3.4.1 Rheumatoid Arthritis Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Rheumatoid Arthritis Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Rheumatoid Arthritis Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Rheumatoid Arthritis Drugs Market Size by Type (2015-2020)
4.1.1 Global Rheumatoid Arthritis Drugs Sales by Type (2015-2020)
4.1.2 Global Rheumatoid Arthritis Drugs Revenue by Type (2015-2020)
4.1.3 Rheumatoid Arthritis Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Rheumatoid Arthritis Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Rheumatoid Arthritis Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Rheumatoid Arthritis Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Rheumatoid Arthritis Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Rheumatoid Arthritis Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Rheumatoid Arthritis Drugs Market Size by Application (2015-2020)
5.1.1 Global Rheumatoid Arthritis Drugs Sales by Application (2015-2020)
5.1.2 Global Rheumatoid Arthritis Drugs Revenue by Application (2015-2020)
5.1.3 Rheumatoid Arthritis Drugs Price by Application (2015-2020)
5.2 Rheumatoid Arthritis Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Rheumatoid Arthritis Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Rheumatoid Arthritis Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Rheumatoid Arthritis Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Rheumatoid Arthritis Drugs by Country
6.1.1 North America Rheumatoid Arthritis Drugs Sales by Country
6.1.2 North America Rheumatoid Arthritis Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Rheumatoid Arthritis Drugs Market Facts & Figures by Type
6.3 North America Rheumatoid Arthritis Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Rheumatoid Arthritis Drugs by Country
7.1.1 Europe Rheumatoid Arthritis Drugs Sales by Country
7.1.2 Europe Rheumatoid Arthritis Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Rheumatoid Arthritis Drugs Market Facts & Figures by Type
7.3 Europe Rheumatoid Arthritis Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Rheumatoid Arthritis Drugs by Region
8.1.1 Asia Pacific Rheumatoid Arthritis Drugs Sales by Region
8.1.2 Asia Pacific Rheumatoid Arthritis Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Rheumatoid Arthritis Drugs Market Facts & Figures by Type
8.3 Asia Pacific Rheumatoid Arthritis Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Rheumatoid Arthritis Drugs by Country
9.1.1 Latin America Rheumatoid Arthritis Drugs Sales by Country
9.1.2 Latin America Rheumatoid Arthritis Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Rheumatoid Arthritis Drugs Market Facts & Figures by Type
9.3 Central & South America Rheumatoid Arthritis Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Rheumatoid Arthritis Drugs by Country
10.1.1 Middle East and Africa Rheumatoid Arthritis Drugs Sales by Country
10.1.2 Middle East and Africa Rheumatoid Arthritis Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Rheumatoid Arthritis Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Rheumatoid Arthritis Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Description and Business Overview
11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Rheumatoid Arthritis Drugs Products Offered
11.1.5 AbbVie Related Developments
11.2 Amgen
11.2.1 Amgen Corporation Information
11.2.2 Amgen Description and Business Overview
11.2.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Amgen Rheumatoid Arthritis Drugs Products Offered
11.2.5 Amgen Related Developments
11.3 Bayer
11.3.1 Bayer Corporation Information
11.3.2 Bayer Description and Business Overview
11.3.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bayer Rheumatoid Arthritis Drugs Products Offered
11.3.5 Bayer Related Developments
11.4 Biogen
11.4.1 Biogen Corporation Information
11.4.2 Biogen Description and Business Overview
11.4.3 Biogen Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Biogen Rheumatoid Arthritis Drugs Products Offered
11.4.5 Biogen Related Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Corporation Information
11.5.2 Boehringer Ingelheim Description and Business Overview
11.5.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Boehringer Ingelheim Rheumatoid Arthritis Drugs Products Offered
11.5.5 Boehringer Ingelheim Related Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Corporation Information
11.6.2 Bristol-Myers Squibb Description and Business Overview
11.6.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bristol-Myers Squibb Rheumatoid Arthritis Drugs Products Offered
11.6.5 Bristol-Myers Squibb Related Developments
11.7 F. Hoffmann-La Roche
11.7.1 F. Hoffmann-La Roche Corporation Information
11.7.2 F. Hoffmann-La Roche Description and Business Overview
11.7.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.7.4 F. Hoffmann-La Roche Rheumatoid Arthritis Drugs Products Offered
11.7.5 F. Hoffmann-La Roche Related Developments
11.8 Johnson and Johnson
11.8.1 Johnson and Johnson Corporation Information
11.8.2 Johnson and Johnson Description and Business Overview
11.8.3 Johnson and Johnson Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Johnson and Johnson Rheumatoid Arthritis Drugs Products Offered
11.8.5 Johnson and Johnson Related Developments
11.9 Merck
11.9.1 Merck Corporation Information
11.9.2 Merck Description and Business Overview
11.9.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Merck Rheumatoid Arthritis Drugs Products Offered
11.9.5 Merck Related Developments
11.10 Mitsubishi Tanabe Pharma
11.10.1 Mitsubishi Tanabe Pharma Corporation Information
11.10.2 Mitsubishi Tanabe Pharma Description and Business Overview
11.10.3 Mitsubishi Tanabe Pharma Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Mitsubishi Tanabe Pharma Rheumatoid Arthritis Drugs Products Offered
11.10.5 Mitsubishi Tanabe Pharma Related Developments
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Description and Business Overview
11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Rheumatoid Arthritis Drugs Products Offered
11.1.5 AbbVie Related Developments
11.12 Pfizer
11.12.1 Pfizer Corporation Information
11.12.2 Pfizer Description and Business Overview
11.12.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Pfizer Products Offered
11.12.5 Pfizer Related Developments
11.13 UCB S.A
11.13.1 UCB S.A Corporation Information
11.13.2 UCB S.A Description and Business Overview
11.13.3 UCB S.A Sales, Revenue and Gross Margin (2015-2020)
11.13.4 UCB S.A Products Offered
11.13.5 UCB S.A Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Rheumatoid Arthritis Drugs Market Estimates and Projections by Region
12.1.1 Global Rheumatoid Arthritis Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Rheumatoid Arthritis Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Rheumatoid Arthritis Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Rheumatoid Arthritis Drugs Sales Forecast (2021-2026)
12.2.2 North America: Rheumatoid Arthritis Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Rheumatoid Arthritis Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Rheumatoid Arthritis Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Rheumatoid Arthritis Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Rheumatoid Arthritis Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Rheumatoid Arthritis Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Rheumatoid Arthritis Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Rheumatoid Arthritis Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Rheumatoid Arthritis Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Rheumatoid Arthritis Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Rheumatoid Arthritis Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Rheumatoid Arthritis Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Rheumatoid Arthritis Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Rheumatoid Arthritis Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Rheumatoid Arthritis Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Rheumatoid Arthritis Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Rheumatoid Arthritis Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Rheumatoid Arthritis Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Rheumatoid Arthritis Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Rheumatoid Arthritis Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Rheumatoid Arthritis Drugs Market Segments
Table 2. Ranking of Global Top Rheumatoid Arthritis Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Rheumatoid Arthritis Drugs Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Prescription Drugs
Table 5. Major Manufacturers of Over-the-counter Drugs
Table 6. Global Rheumatoid Arthritis Drugs Market Size Growth Rate by Application 2020-2026 (MT)
Table 7. Global Rheumatoid Arthritis Drugs Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 8. Global Rheumatoid Arthritis Drugs Sales by Regions 2015-2020 (MT)
Table 9. Global Rheumatoid Arthritis Drugs Sales Market Share by Regions (2015-2020)
Table 10. Global Rheumatoid Arthritis Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Rheumatoid Arthritis Drugs Sales by Manufacturers (2015-2020) (MT)
Table 12. Global Rheumatoid Arthritis Drugs Sales Share by Manufacturers (2015-2020)
Table 13. Global Rheumatoid Arthritis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Rheumatoid Arthritis Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rheumatoid Arthritis Drugs as of 2019)
Table 15. Rheumatoid Arthritis Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Rheumatoid Arthritis Drugs Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Rheumatoid Arthritis Drugs Price (2015-2020) (USD/Kg)
Table 18. Rheumatoid Arthritis Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Rheumatoid Arthritis Drugs Product Type
Table 20. Date of International Manufacturers Enter into Rheumatoid Arthritis Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Rheumatoid Arthritis Drugs Sales by Type (2015-2020) (MT)
Table 23. Global Rheumatoid Arthritis Drugs Sales Share by Type (2015-2020)
Table 24. Global Rheumatoid Arthritis Drugs Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Rheumatoid Arthritis Drugs Revenue Share by Type (2015-2020)
Table 26. Rheumatoid Arthritis Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 27. Global Rheumatoid Arthritis Drugs Sales by Application (2015-2020) (MT)
Table 28. Global Rheumatoid Arthritis Drugs Sales Share by Application (2015-2020)
Table 29. North America Rheumatoid Arthritis Drugs Sales by Country (2015-2020) (MT)
Table 30. North America Rheumatoid Arthritis Drugs Sales Market Share by Country (2015-2020)
Table 31. North America Rheumatoid Arthritis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Rheumatoid Arthritis Drugs Revenue Market Share by Country (2015-2020)
Table 33. North America Rheumatoid Arthritis Drugs Sales by Type (2015-2020) (MT)
Table 34. North America Rheumatoid Arthritis Drugs Sales Market Share by Type (2015-2020)
Table 35. North America Rheumatoid Arthritis Drugs Sales by Application (2015-2020) (MT)
Table 36. North America Rheumatoid Arthritis Drugs Sales Market Share by Application (2015-2020)
Table 37. Europe Rheumatoid Arthritis Drugs Sales by Country (2015-2020) (MT)
Table 38. Europe Rheumatoid Arthritis Drugs Sales Market Share by Country (2015-2020)
Table 39. Europe Rheumatoid Arthritis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Rheumatoid Arthritis Drugs Revenue Market Share by Country (2015-2020)
Table 41. Europe Rheumatoid Arthritis Drugs Sales by Type (2015-2020) (MT)
Table 42. Europe Rheumatoid Arthritis Drugs Sales Market Share by Type (2015-2020)
Table 43. Europe Rheumatoid Arthritis Drugs Sales by Application (2015-2020) (MT)
Table 44. Europe Rheumatoid Arthritis Drugs Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Rheumatoid Arthritis Drugs Sales by Region (2015-2020) (MT)
Table 46. Asia Pacific Rheumatoid Arthritis Drugs Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Rheumatoid Arthritis Drugs Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Rheumatoid Arthritis Drugs Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Rheumatoid Arthritis Drugs Sales by Type (2015-2020) (MT)
Table 50. Asia Pacific Rheumatoid Arthritis Drugs Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Rheumatoid Arthritis Drugs Sales by Application (2015-2020) (MT)
Table 52. Asia Pacific Rheumatoid Arthritis Drugs Sales Market Share by Application (2015-2020)
Table 53. Latin America Rheumatoid Arthritis Drugs Sales by Country (2015-2020) (MT)
Table 54. Latin America Rheumatoid Arthritis Drugs Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Rheumatoid Arthritis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Rheumatoid Arthritis Drugs Revenue Market Share by Country (2015-2020)
Table 57. Latin America Rheumatoid Arthritis Drugs Sales by Type (2015-2020) (MT)
Table 58. Latin America Rheumatoid Arthritis Drugs Sales Market Share by Type (2015-2020)
Table 59. Latin America Rheumatoid Arthritis Drugs Sales by Application (2015-2020) (MT)
Table 60. Latin America Rheumatoid Arthritis Drugs Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Rheumatoid Arthritis Drugs Sales by Country (2015-2020) (MT)
Table 62. Middle East and Africa Rheumatoid Arthritis Drugs Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Rheumatoid Arthritis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Rheumatoid Arthritis Drugs Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Rheumatoid Arthritis Drugs Sales by Type (2015-2020) (MT)
Table 66. Middle East and Africa Rheumatoid Arthritis Drugs Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Rheumatoid Arthritis Drugs Sales by Application (2015-2020) (MT)
Table 68. Middle East and Africa Rheumatoid Arthritis Drugs Sales Market Share by Application (2015-2020)
Table 69. AbbVie Corporation Information
Table 70. AbbVie Description and Major Businesses
Table 71. AbbVie Rheumatoid Arthritis Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 72. AbbVie Product
Table 73. AbbVie Recent Development
Table 74. Amgen Corporation Information
Table 75. Amgen Description and Major Businesses
Table 76. Amgen Rheumatoid Arthritis Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 77. Amgen Product
Table 78. Amgen Recent Development
Table 79. Bayer Corporation Information
Table 80. Bayer Description and Major Businesses
Table 81. Bayer Rheumatoid Arthritis Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 82. Bayer Product
Table 83. Bayer Recent Development
Table 84. Biogen Corporation Information
Table 85. Biogen Description and Major Businesses
Table 86. Biogen Rheumatoid Arthritis Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 87. Biogen Product
Table 88. Biogen Recent Development
Table 89. Boehringer Ingelheim Corporation Information
Table 90. Boehringer Ingelheim Description and Major Businesses
Table 91. Boehringer Ingelheim Rheumatoid Arthritis Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 92. Boehringer Ingelheim Product
Table 93. Boehringer Ingelheim Recent Development
Table 94. Bristol-Myers Squibb Corporation Information
Table 95. Bristol-Myers Squibb Description and Major Businesses
Table 96. Bristol-Myers Squibb Rheumatoid Arthritis Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 97. Bristol-Myers Squibb Product
Table 98. Bristol-Myers Squibb Recent Development
Table 99. F. Hoffmann-La Roche Corporation Information
Table 100. F. Hoffmann-La Roche Description and Major Businesses
Table 101. F. Hoffmann-La Roche Rheumatoid Arthritis Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 102. F. Hoffmann-La Roche Product
Table 103. F. Hoffmann-La Roche Recent Development
Table 104. Johnson and Johnson Corporation Information
Table 105. Johnson and Johnson Description and Major Businesses
Table 106. Johnson and Johnson Rheumatoid Arthritis Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 107. Johnson and Johnson Product
Table 108. Johnson and Johnson Recent Development
Table 109. Merck Corporation Information
Table 110. Merck Description and Major Businesses
Table 111. Merck Rheumatoid Arthritis Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 112. Merck Product
Table 113. Merck Recent Development
Table 114. Mitsubishi Tanabe Pharma Corporation Information
Table 115. Mitsubishi Tanabe Pharma Description and Major Businesses
Table 116. Mitsubishi Tanabe Pharma Rheumatoid Arthritis Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. Mitsubishi Tanabe Pharma Product
Table 118. Mitsubishi Tanabe Pharma Recent Development
Table 119. Novartis Corporation Information
Table 120. Novartis Description and Major Businesses
Table 121. Novartis Rheumatoid Arthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 122. Novartis Product
Table 123. Novartis Recent Development
Table 124. Pfizer Corporation Information
Table 125. Pfizer Description and Major Businesses
Table 126. Pfizer Rheumatoid Arthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 127. Pfizer Product
Table 128. Pfizer Recent Development
Table 129. UCB S.A Corporation Information
Table 130. UCB S.A Description and Major Businesses
Table 131. UCB S.A Rheumatoid Arthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 132. UCB S.A Product
Table 133. UCB S.A Recent Development
Table 134. Global Rheumatoid Arthritis Drugs Sales Forecast by Regions (2021-2026) (MT)
Table 135. Global Rheumatoid Arthritis Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 136. Global Rheumatoid Arthritis Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 137. Global Rheumatoid Arthritis Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 138. North America: Rheumatoid Arthritis Drugs Sales Forecast by Country (2021-2026) (MT)
Table 139. North America: Rheumatoid Arthritis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Europe: Rheumatoid Arthritis Drugs Sales Forecast by Country (2021-2026) (MT)
Table 141. Europe: Rheumatoid Arthritis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Asia Pacific: Rheumatoid Arthritis Drugs Sales Forecast by Region (2021-2026) (MT)
Table 143. Asia Pacific: Rheumatoid Arthritis Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 144. Latin America: Rheumatoid Arthritis Drugs Sales Forecast by Country (2021-2026) (MT)
Table 145. Latin America: Rheumatoid Arthritis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Middle East and Africa: Rheumatoid Arthritis Drugs Sales Forecast by Country (2021-2026) (MT)
Table 147. Middle East and Africa: Rheumatoid Arthritis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 149. Key Challenges
Table 150. Market Risks
Table 151. Main Points Interviewed from Key Rheumatoid Arthritis Drugs Players
Table 152. Rheumatoid Arthritis Drugs Customers List
Table 153. Rheumatoid Arthritis Drugs Distributors List
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Rheumatoid Arthritis Drugs Product Picture
Figure 2. Global Rheumatoid Arthritis Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Prescription Drugs Product Picture
Figure 4. Over-the-counter Drugs Product Picture
Figure 5. Global Rheumatoid Arthritis Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Nursing home
Figure 9. Other
Figure 10. Rheumatoid Arthritis Drugs Report Years Considered
Figure 11. Global Rheumatoid Arthritis Drugs Market Size 2015-2026 (US$ Million)
Figure 12. Global Rheumatoid Arthritis Drugs Sales 2015-2026 (MT)
Figure 13. Global Rheumatoid Arthritis Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Rheumatoid Arthritis Drugs Sales Market Share by Region (2015-2020)
Figure 15. Global Rheumatoid Arthritis Drugs Sales Market Share by Region in 2019
Figure 16. Global Rheumatoid Arthritis Drugs Revenue Market Share by Region (2015-2020)
Figure 17. Global Rheumatoid Arthritis Drugs Revenue Market Share by Region in 2019
Figure 18. Global Rheumatoid Arthritis Drugs Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Rheumatoid Arthritis Drugs Revenue in 2019
Figure 20. Rheumatoid Arthritis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Rheumatoid Arthritis Drugs Sales Market Share by Type (2015-2020)
Figure 22. Global Rheumatoid Arthritis Drugs Sales Market Share by Type in 2019
Figure 23. Global Rheumatoid Arthritis Drugs Revenue Market Share by Type (2015-2020)
Figure 24. Global Rheumatoid Arthritis Drugs Revenue Market Share by Type in 2019
Figure 25. Global Rheumatoid Arthritis Drugs Market Share by Price Range (2015-2020)
Figure 26. Global Rheumatoid Arthritis Drugs Sales Market Share by Application (2015-2020)
Figure 27. Global Rheumatoid Arthritis Drugs Sales Market Share by Application in 2019
Figure 28. Global Rheumatoid Arthritis Drugs Revenue Market Share by Application (2015-2020)
Figure 29. Global Rheumatoid Arthritis Drugs Revenue Market Share by Application in 2019
Figure 30. North America Rheumatoid Arthritis Drugs Sales Growth Rate 2015-2020 (MT)
Figure 31. North America Rheumatoid Arthritis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Rheumatoid Arthritis Drugs Sales Market Share by Country in 2019
Figure 33. North America Rheumatoid Arthritis Drugs Revenue Market Share by Country in 2019
Figure 34. U.S. Rheumatoid Arthritis Drugs Sales Growth Rate (2015-2020) (MT)
Figure 35. U.S. Rheumatoid Arthritis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Rheumatoid Arthritis Drugs Sales Growth Rate (2015-2020) (MT)
Figure 37. Canada Rheumatoid Arthritis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Rheumatoid Arthritis Drugs Market Share by Type in 2019
Figure 39. North America Rheumatoid Arthritis Drugs Market Share by Application in 2019
Figure 40. Europe Rheumatoid Arthritis Drugs Sales Growth Rate 2015-2020 (MT)
Figure 41. Europe Rheumatoid Arthritis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Rheumatoid Arthritis Drugs Sales Market Share by Country in 2019
Figure 43. Europe Rheumatoid Arthritis Drugs Revenue Market Share by Country in 2019
Figure 44. Germany Rheumatoid Arthritis Drugs Sales Growth Rate (2015-2020) (MT)
Figure 45. Germany Rheumatoid Arthritis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Rheumatoid Arthritis Drugs Sales Growth Rate (2015-2020) (MT)
Figure 47. France Rheumatoid Arthritis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Rheumatoid Arthritis Drugs Sales Growth Rate (2015-2020) (MT)
Figure 49. U.K. Rheumatoid Arthritis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Rheumatoid Arthritis Drugs Sales Growth Rate (2015-2020) (MT)
Figure 51. Italy Rheumatoid Arthritis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Rheumatoid Arthritis Drugs Sales Growth Rate (2015-2020) (MT)
Figure 53. Russia Rheumatoid Arthritis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Rheumatoid Arthritis Drugs Market Share by Type in 2019
Figure 55. Europe Rheumatoid Arthritis Drugs Market Share by Application in 2019
Figure 56. Asia Pacific Rheumatoid Arthritis Drugs Sales Growth Rate 2015-2020 (MT)
Figure 57. Asia Pacific Rheumatoid Arthritis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Rheumatoid Arthritis Drugs Sales Market Share by Region in 2019
Figure 59. Asia Pacific Rheumatoid Arthritis Drugs Revenue Market Share by Region in 2019
Figure 60. China Rheumatoid Arthritis Drugs Sales Growth Rate (2015-2020) (MT)
Figure 61. China Rheumatoid Arthritis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Rheumatoid Arthritis Drugs Sales Growth Rate (2015-2020) (MT)
Figure 63. Japan Rheumatoid Arthritis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Rheumatoid Arthritis Drugs Sales Growth Rate (2015-2020) (MT)
Figure 65. South Korea Rheumatoid Arthritis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Rheumatoid Arthritis Drugs Sales Growth Rate (2015-2020) (MT)
Figure 67. India Rheumatoid Arthritis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Rheumatoid Arthritis Drugs Sales Growth Rate (2015-2020) (MT)
Figure 69. Australia Rheumatoid Arthritis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Rheumatoid Arthritis Drugs Sales Growth Rate (2015-2020) (MT)
Figure 71. Taiwan Rheumatoid Arthritis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Rheumatoid Arthritis Drugs Sales Growth Rate (2015-2020) (MT)
Figure 73. Indonesia Rheumatoid Arthritis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Rheumatoid Arthritis Drugs Sales Growth Rate (2015-2020) (MT)
Figure 75. Thailand Rheumatoid Arthritis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Rheumatoid Arthritis Drugs Sales Growth Rate (2015-2020) (MT)
Figure 77. Malaysia Rheumatoid Arthritis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Rheumatoid Arthritis Drugs Sales Growth Rate (2015-2020) (MT)
Figure 79. Philippines Rheumatoid Arthritis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Rheumatoid Arthritis Drugs Sales Growth Rate (2015-2020) (MT)
Figure 81. Vietnam Rheumatoid Arthritis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Rheumatoid Arthritis Drugs Market Share by Type in 2019
Figure 83. Asia Pacific Rheumatoid Arthritis Drugs Market Share by Application in 2019
Figure 84. Latin America Rheumatoid Arthritis Drugs Sales Growth Rate 2015-2020 (MT)
Figure 85. Latin America Rheumatoid Arthritis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Rheumatoid Arthritis Drugs Sales Market Share by Country in 2019
Figure 87. Latin America Rheumatoid Arthritis Drugs Revenue Market Share by Country in 2019
Figure 88. Mexico Rheumatoid Arthritis Drugs Sales Growth Rate (2015-2020) (MT)
Figure 89. Mexico Rheumatoid Arthritis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Rheumatoid Arthritis Drugs Sales Growth Rate (2015-2020) (MT)
Figure 91. Brazil Rheumatoid Arthritis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Rheumatoid Arthritis Drugs Sales Growth Rate (2015-2020) (MT)
Figure 93. Argentina Rheumatoid Arthritis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Rheumatoid Arthritis Drugs Market Share by Type in 2019
Figure 95. Latin America Rheumatoid Arthritis Drugs Market Share by Application in 2019
Figure 96. Middle East and Africa Rheumatoid Arthritis Drugs Sales Growth Rate 2015-2020 (MT)
Figure 97. Middle East and Africa Rheumatoid Arthritis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Rheumatoid Arthritis Drugs Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Rheumatoid Arthritis Drugs Revenue Market Share by Country in 2019
Figure 100. Turkey Rheumatoid Arthritis Drugs Sales Growth Rate (2015-2020) (MT)
Figure 101. Turkey Rheumatoid Arthritis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Rheumatoid Arthritis Drugs Sales Growth Rate (2015-2020) (MT)
Figure 103. Saudi Arabia Rheumatoid Arthritis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Rheumatoid Arthritis Drugs Sales Growth Rate (2015-2020) (MT)
Figure 105. U.A.E Rheumatoid Arthritis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Rheumatoid Arthritis Drugs Market Share by Type in 2019
Figure 107. Middle East and Africa Rheumatoid Arthritis Drugs Market Share by Application in 2019
Figure 108. North America Rheumatoid Arthritis Drugs Sales Growth Rate Forecast (2021-2026) (MT)
Figure 109. North America Rheumatoid Arthritis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Rheumatoid Arthritis Drugs Sales Growth Rate Forecast (2021-2026) (MT)
Figure 111. Europe Rheumatoid Arthritis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Rheumatoid Arthritis Drugs Sales Growth Rate Forecast (2021-2026) (MT)
Figure 113. Asia Pacific Rheumatoid Arthritis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Rheumatoid Arthritis Drugs Sales Growth Rate Forecast (2021-2026) (MT)
Figure 115. Latin America Rheumatoid Arthritis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Rheumatoid Arthritis Drugs Sales Growth Rate Forecast (2021-2026) (MT)
Figure 117. Middle East and Africa Rheumatoid Arthritis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
関節リウマチ治療の世界市場（～2026年） Rheumatoid arthritis is a long-term autoimmune disorder that primarily affects joints. The rheumatoid arthritis treatment market is expected to grow over the forecast period owing to the high incidence rate of rheumatoid arthritis among people. Market Analysis and Insights: Global Rheumatoid Arthrit…- 関節リウマチ診断検査の世界市場（～2026年） Rheumatoid arthritis is a long-term autoimmune disorder that primarily affects joints. The goals of rheumatoid arthritis treatment are to reduce pain, decrease inflammation and improve a person's overall functioning. Market Analysis and Insights: Global Rheumatoid Arthritis Diagnosis Tests Market Th…
- 血清反応陽性用関節リウマチ治療薬の世界市場（～2026年） Arthritis means inflammation in a joint. The inflammation is characterized by swelling, pain, and redness within the joint. This type of arthritis is known to cause chronic inflammatory disorder in the hands and feet. The Americas dominated the overall market in terms of revenue in 2016 owing to the…
- 自己免疫治療薬の世界市場（～2026年） Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by c…
- 生物学的治療薬の世界市場（～2026年） Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural s…